Drugs / HX-1171
HX-1171
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01548391 | Mar 2012 → ? | — | Biotoxtech Co., Ltd | Unknown | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT01889745 | — | — | Biotoxtech Co., Ltd | Temporarily not available | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HX-1171 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01548391 ↗ |
| Known as | Hexyloxy trimethylphenol | ChEMBL registry synonym — accepted as the source's own label CHEMBL3182532 ↗ |
| Known as | Hthq | ChEMBL registry synonym — accepted as the source's own label CHEMBL3182532 ↗ |
| Modality | Small molecule | — CHEMBL3182532 ↗ |